US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist

5.560
+0.200+3.73%

Close Oct 16 16:00 ET

5.650
+0.090+1.62%

Post 20:02 ET

330.38MMarket Cap-8687P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aldeyra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 24.875M	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 1.000M	--
--	2023/Q4	0.000 / 2.429M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 24.875M--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 1.000M--

--2023/Q40.000 / 2.429M--

Unlock Free Earnings Estimates

Open Account

Aldeyra Therapeutics Earnings Reports

Aldeyra Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 1 16:10 ET

Aldeyra Therapeutics | 10-Q: Q1 2024 Earnings Report

May 2 16:10 ET

Aldeyra Therapeutics | 10-K: FY2023 Annual Report

Mar 7 16:10 ET

Aldeyra Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 3, 2023 16:08 ET

Analyst Rating

Updated: Oct 16, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall